Endocrine Gastroenteropancreatic Tumors

@inproceedings{Kwekkeboom2005EndocrineGT,
  title={Endocrine Gastroenteropancreatic Tumors},
  author={Dik J. Kwekkeboom and Jaap J. M. Teunissen and Willem Hendrik Bakker and Peter P. M. Kooij and Wouter W. de Herder and R A Richard Feelders and Casper HJ van Eijck and Jan-Paul Esser and Boen Liong Kam and Eric Paul Krenning},
  year={2005}
}
Purpose There are few treatment options for patients with metastasized or inoperable endocrine gastroenteropancreatic (GEP) tumors. Chemotherapy can be effective, but the response is usually less than 1 year. Here, we present the results of treatment with a radiolabeled somatostatin analog, [ 177 Lu-DOTA 0 ,Tyr 3 ]octreotate ( 177 Lu-octreotate). Patients and Methods One hundred thirty-one patients with somatostatin receptor–positive tumors were treated with up to a cumulative dose of 600 to… CONTINUE READING

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 86 CITATIONS, ESTIMATED 30% COVERAGE

Advances in Peptide Receptor Radionuclide Therapy.

  • Seminars in nuclear medicine
  • 2016
VIEW 11 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

High expression of neuropeptide Y1 receptors in ewing sarcoma tumors.

  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2008
VIEW 8 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Changing role of somatostatin receptor targeted drugs in NET: Nuclear Medicine's view.

  • Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques
  • 2007
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2005
2019

CITATION STATISTICS

  • 11 Highly Influenced Citations

  • Averaged 3 Citations per year over the last 3 years

Similar Papers

Loading similar papers…